S
GSK icon

SignatureFD’s GSK GSK Stock Holding History

SignatureFD’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,000
Closed -$2K – 1095
2015
Q1 		$2K Buy
+4,000
New +$229K ﹤0.01% 803
2014
Q4 		– Sell
-1,200
Closed -$2K – 905
2014
Q3 		$2K Buy
+1,200
New +$73.6K ﹤0.01% 590

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SignatureFD's GSK Position: Q1 2026 in Review

SignatureFD increased its GSK (GSK) stake by 3.6% in Q1 2026, buying an estimated $86.2K and bringing the position to 46,265 shares worth $2.55M. The position accounts for 0.04% of the portfolio, ranked #186.

SignatureFD first reported a position in GSK in Q2 2013 and has held it in 49 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • SignatureFD held 46,265 shares of GSK worth $2.55M as of Q1 2026.
  • SignatureFD bought 1,591 GSK shares in Q1 2026, an estimated $86.2K.
  • GSK made up 0.04% of SignatureFD's portfolio in Q1 2026, its #186 holding.
  • SignatureFD first reported a position in GSK in Q2 2013 and has held it in 49 quarters since.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.